South African Law Enforcement Urged to Act Against Unregulated Weight Loss Drugs
South African regulatory authorities, pharmaceutical manufacturers, and healthcare professionals are pressing law enforcement to intervene in the escalating sale of unregistered weight loss medications. BusinessTech reported that illicit drugs are increasingly distributed through online platforms, social media, messaging apps, and wellness clinics, creating significant patient safety and economic risks.
Scale of the Illicit Pharmaceutical Trade
The South African Health Products Regulatory Authority (SAHPRA) has logged approximately 600 complaints regarding informal, illegitimate, and falsified products sold through unauthorized channels. Daphney Fafudi, Market Control Senior Manager at SAHPRA, highlighted the core danger to consumers purchasing outside formal supply chains. Patients often focus on whether a medicine works, but the real question is whether anyone knows what is in that product, whether it was manufactured correctly, whether it contains the correct ingredients, and whether it has been appropriately assessed and authorised,
Fafudi said.
Border enforcement figures illustrate the massive scale of the illicit trade. The Border Management Authority (BMA) reported intercepting more than 1.7 million suspicious pharmaceutical-related products via border protocols. Beyond weight loss treatments, high-demand items moving through these informal markets include codeine-containing medicines, skin-lightening products, and performance-enhancing substances.
Illicit Importation of Experimental GLP-1 Products
Stavros Nicolaou, Chairperson of the Pharmaceutical Task Group (PTG) and Senior Executive for Strategic Trade at Aspen Pharmacare, told Cape Talk that even registered medicines are entering the country illicitly through non-compliant sources lacking quality approvals. Nicolaou noted that the crisis has intensified with surging global demand for GLP-1 weight loss treatments.
Among the unauthorized products appearing in local markets is retatrutide, an experimental once-weekly injectable developed by Eli Lilly and Company to target obesity, type 2 diabetes, and metabolic disorders. Retatrutide is a medicine that is showing a lot of potential, but it is still in the experimental stage, so in other words, it’s still undergoing clinical trials to determine the quality, safety, and efficacy of the product,
Nicolaou said. He added that the appearance of copies of an unapproved, unverified drug before registration anywhere in the world is unprecedented in his 40 years in the industry.
Smugglers frequently bypass standard controls by shipping unauthorized peptides and counterfeit GLP-1 products through ports disguised as items such as cat food or vitamins. These shipments often bypass healthcare professionals entirely, ending up in the hands of beauty salons, gym instructors, and hairdressers.
Economic Crime and Regulatory Collaboration
Nicolaou emphasized that the distribution of unregistered medications extends beyond public health to threaten the national economy. Healthcare crime is both a patient-safety issue and an economic-crime issue,
Nicolaou stated, warning that it undermines legitimate businesses, discourages investment, and diverts economic activity away from the formal sector.
Because organized criminal networks exploit fragmented oversight systems, PTG officials stress that regulatory bodies, customs authorities, professional councils, and industry stakeholders must coordinate enforcement efforts. Nicolaou warned that failing to protect the pharmaceutical value chain threatens the integrity of the country’s broader regulatory framework and risks compromising clinical trial outcomes if safety protocols are rushed.
Frequently Asked Questions
What specific unauthorized products are entering South Africa?
Authorities have intercepted experimental treatments like retatrutide, counterfeit GLP-1 weight loss products, peptide formulations, codeine-containing medicines, skin-lightening products, and performance-enhancing substances.
How many complaints have authorities received regarding falsified products?
SAHPRA has recorded approximately 600 complaints concerning informal, illegitimate, and falsified medical products sold through unauthorized channels.
How are smugglers bringing these unregistered drugs into the country?
The Border Management Authority reported intercepting over 1.7 million suspicious pharmaceutical-related products. Smugglers frequently disguise these shipments—such as peptides and counterfeit GLP-1s—as everyday goods like cat food or vitamins at ports of entry.